Royal Bank of Canada »

Prelude Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-03-31 $0 2.1k 0.00
2023-12-31 $39k 9.0k 4.34
2023-09-30 $16k 5.1k 3.12
2023-06-30 $23k 5.3k 4.32
2022-12-31 $0 4.3k 0.00
2022-09-30 $29k 4.2k 6.80
2021-06-30 $104k 3.7k 28.46
2021-03-31 $150k 3.4k 43.58
2020-12-31 $208k 2.8k 73.59